 |
Ivax Corporation to develop novel oral drug for cancer
Tuesday, October 05, 2004 10:00 IST
Miami
HMN-214 was developed by Nippon Shinyaku and targets polo-like kinase, an enzyme that is over-expressed by a large number of human malignant tumours
Read complete story ...
(You will need to login first to read this story.)
|
|
|
